J Metab Bariatr Surg.  2022 Dec;11(2):30-38. 10.17476/jmbs.2022.11.2.30.

Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures

• Son SY
• Song JH
• Shin HJ
• Hur H
• Han SU

• KMID: 2552777
• DOI: http://doi.org/10.17476/jmbs.2022.11.2.30

Abstract

Obesity by itself is a factor in the development of gallstone disease, and periods of weight loss after bariatric surgery further increase the risk of gallstone formation. In patients with obesity, hypersecretion of cholesterol may increase the risk of gallstone formation, which is approximately five-fold higher than that in the general population. The incidence of gallstone formation after bariatric surgery is 10–38% and often associated with a proportional increase in the risk of developing biliary complications. Routine postoperative administration of ursodeoxycholic acid (UDCA) is recommended to prevent gallstone formation. Several randomized trials have indicated that UDCA can effectively prevent gallstones and reduce the risk of cholecystectomy after bariatric procedures. The effective daily dose of UDCA in each study ranged from 500 to 1,200 mg, and it may be considered at least during the period of rapid weight loss (first 3–6 months postoperatively) to decrease the incidence of symptomatic gallstones.

Keyword

Morbid obesity; Bariatric surgery; Gallstones; Ursodeoxycholic acid